Medchef Pharmaceuticals Private Limited

Medchef Pharmaceuticals Private Limited - trading in Bahrampur, Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U51900UP2018PTC102305 Incorporated 21 March 2018 ROC Uttar Pradesh HQ Bahrampur, Uttar Pradesh, India
Active Private Limited Company trading MSME · Micro
Data last updated
Revenue · FY 2024
₹78.43 Lakh
▲ 5% YoY
Net profit · FY 2024
₹77,930
Net margin 1%
EBITDA · FY 2024
₹2.41 Lakh
EBITDA margin 3.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
of 2 registered

About Medchef Pharmaceuticals Private Limited

Data last updated:

Medchef Pharmaceuticals Private Limited is a private limited company based in Bahrampur, Uttar Pradesh, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 21 March 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U51900UP2018PTC102305. Its GSTIN is 07AALCM7082N1ZQ (Delhi). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kumar Gupta and Jayhind Kumar.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot – 51 Flat 209 Unione Residency, Bahrampur, Uttar Pradesh, India – 201009.

As per the financials filed for FY 2024, the company reported a revenue of ₹78.43 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹77,930 (net margin 1%) and EBITDA of ₹2.41 Lakh (EBITDA margin 3.1%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 59% over five years.

Medchef Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-05-0006272).

Company details

CIN U51900UP2018PTC102305
Registration Number 102305
Incorporation Date 21 March 2018
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-05-0006272

Recognitions & Rankings of Medchef Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-05-0006272

Contact details

Medchef Pharmaceuticals Private Limited's registered office is in Bahrampur, Uttar Pradesh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot – 51 Flat 209 Unione Residency, Bahrampur, Uttar Pradesh, India – 201009
  • Industry
    Trading, Specialty, Wholesale

To see the full contact details of Medchef Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Medchef Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Medchef Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Medchef Pharmaceuticals Private Limited, buy the company report.

Financials of Medchef Pharmaceuticals Private Limited

FY 2025 filings available

Medchef Pharmaceuticals Private Limited reported revenue of ₹78.43 Lakh (up 5% YoY) for FY 2024.

Revenue · FY 2024
₹78.43 Lakh ▲ 5%
Net profit · FY 2024
₹77,930 margin 1%
EBITDA · FY 2024
₹2.41 Lakh margin 3.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 28%
5 years · compounded
▲ 59%
EBITDA CAGR growth
1 year
▲ 142%
3 years · compounded
▲ 44%
5 years · compounded
▲ 66%

Revenue has grown at a compounded annual rate (CAGR) of 59% over five years, including 5% growth in the latest year. EBITDA rose 142% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.41 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹77,930
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.1%
Net Profit Margin1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Medchef Pharmaceuticals Private Limited, buy the company report.

Board of directors of Medchef Pharmaceuticals Private Limited

Medchef Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Anil Kumar GuptaDirector21 Mar 20188 Years 7 MonthsCurrent
Jayhind KumarDirector21 Mar 20188 Years 7 MonthsCurrent

Peer comparison

Medchef Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Agshov Pharmaceuticals Private Limited₹78.43 Lakh (FY 2024)9.0%North Twenty Four Pargana, West Bengal, India
Medchef Pharmaceuticals Private Limitedthis company₹78.43 Lakh (FY 2024)₹77,9301%5.0%Bahrampur, Uttar Pradesh, India
Svap Pharmaceuticals Private Limited₹78.36 Lakh (FY 2025)41.0%Gorakhpur, Uttar Pradesh, India
Faith Pharmaceuticals Limited₹78.18 Lakh (FY 2025)4.0%New Delhi, Delhi, India
Medechem Pharmaceuticals (OPC) Private Limited₹77.96 Lakh (FY 2025)-23.0%New Delhi, Delhi, India

To see the full peer comparison of Medchef Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Medchef Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Medchef Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
07AALCM7082N1ZQDelhiActive11 Apr 2018

To see the full GST registrations and return filing status of Medchef Pharmaceuticals Private Limited, buy the company report.

Recent activity

Medchef Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Anil Kumar Gupta was appointed as Director on 21 Mar 2018.

AGM
Medchef Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medchef Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii.
Appointed
Anil Kumar Gupta was appointed as Director.
Appointed
Jayhind Kumar was appointed as Director.
Incorporation
21 Mar 2018
Medchef Pharmaceuticals Private Limited was registered on 21 Mar 2018 with Roc Uttar Pradesh Ii & aged 8 years 7 months as per MCA records.

Frequently asked questions

Medchef Pharmaceuticals is an active private limited company based in Bahrampur, Uttar Pradesh, India. The company works in specialty, within the trading industry. It was incorporated on 21 March 2018 (8+ years old) and is registered under CIN U51900UP2018PTC102305.

Medchef Pharmaceuticals has 2 current directors:

The latest financial statements of Medchef Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Medchef Pharmaceuticals is 07AALCM7082N1ZQ, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Medchef Pharmaceuticals is U51900UP2018PTC102305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Medchef Pharmaceuticals was incorporated on 21 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

The peers of Medchef Pharmaceuticals by revenue are Agshov Pharmaceuticals Private Limited, Svap Pharmaceuticals Private Limited, Faith Pharmaceuticals Limited, Medechem Pharmaceuticals (OPC) Private Limited, all in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), with the same principal business activity (wholesale trading).

Anil Kumar Gupta was appointed as Director on 21 Mar 2018. Jayhind Kumar was appointed as Director on 21 Mar 2018.

Yes, Medchef Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-05-0006272).

The registered office of Medchef Pharmaceuticals is at Plot – 51 Flat 209 Unione Residency, Bahrampur, Uttar Pradesh, India – 201009.

Medchef Pharmaceuticals operates in the trading industry, in the specialty segment.